KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Equity (2016 - 2025)

Historic Return on Equity for Sarepta Therapeutics (SRPT) over the last 14 years, with Q3 2025 value amounting to 0.27%.

  • Sarepta Therapeutics' Return on Equity rose 1600.0% to 0.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.27%, marking a year-over-year increase of 1600.0%. This contributed to the annual value of 0.2% for FY2024, which is 10600.0% up from last year.
  • As of Q3 2025, Sarepta Therapeutics' Return on Equity stood at 0.27%, which was up 1600.0% from 0.31% recorded in Q2 2025.
  • In the past 5 years, Sarepta Therapeutics' Return on Equity ranged from a high of 0.31% in Q2 2025 and a low of 2.03% during Q1 2023
  • In the last 5 years, Sarepta Therapeutics' Return on Equity had a median value of 0.64% in 2022 and averaged 0.62%.
  • In the last 5 years, Sarepta Therapeutics' Return on Equity plummeted by -16300bps in 2023 and then soared by 20500bps in 2024.
  • Over the past 5 years, Sarepta Therapeutics' Return on Equity (Quarter) stood at 0.6% in 2021, then crashed by -188bps to 1.73% in 2022, then skyrocketed by 62bps to 0.66% in 2023, then skyrocketed by 126bps to 0.17% in 2024, then soared by 55bps to 0.27% in 2025.
  • Its last three reported values are 0.27% in Q3 2025, 0.31% for Q2 2025, and 0.15% during Q1 2025.